Skip to main content

Nasdaq IPOs

CNS biotech Taysha Gene Therapies sets terms for $125 million IPO

6 years ago
Taysha Gene Therapies, an early stage biotech developing AAV-based gene therapies for CNS disorders, announced terms for its IPO on Thursday. The Dallas, TX-based company plans to raise $125 million by offering 6.6 million shares at a price range of $18 to $20. At the midpoint of
Renaissance Capital

Commercial REIT Broadstone Net Lease prices IPO at $17 low end

6 years ago
Broadstone Net Lease, a single-tenant commercial net lease REIT with 633 properties in the US and Canada, raised $570 million by offering 33.5 million shares at $17, the low end of the range of $17 to $19. The company plans to offer a 5.9% yield based on the offering price. Broad
Renaissance Capital

Europe-focused SPAC Avanti Acquisition files for a $500 million IPO

6 years ago
Avanti Acquisition, a blank check company formed by NNS Group and Sienna Capital targeting a European business, filed on Wednesday with the SEC to raise up to $500 million in an initial public offering. The Cayman Islands-based company plans to raise $500 million by offering 50 m
Renaissance Capital

Investment firm StepStone Group prices IPO above the range at $18

6 years ago
StepStone Group, a global private markets investment firm, raised $315 million by offering 17.5 million shares at $18, above the range of $15 to $17. At pricing, the company raised 13% more proceeds than anticipated. StepStone Group plans to list on the Nasdaq under the symbol ST
Renaissance Capital
Checked
23 minutes 39 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed